Results 131 to 140 of about 60,629 (265)
Bullous Pemphigoid Mimicking Infection in a Diabetic Foot: A Diagnostic Challenge. [PDF]
Alzir MS +5 more
europepmc +1 more source
ABSTRACT Arthrogryposis Multiplex Congenita (AMC) encompasses several hundred conditions with diverse genetic, pathophysiological, and clinical origins. The overarching EXPLAIN study explores underlying causes and implications of AMC and represents the largest clinical cohort of adults with AMC reported to date.
My Vuong Hermansen +5 more
wiley +1 more source
Physiotherapy Intervention for Diabetic Foot Ulcers: A Scoping Review. [PDF]
Imaoka S +4 more
europepmc +1 more source
ABSTRACT Background To systematically evaluate the local biomarkers correlated with olfactory dysfunction (OD) in chronic rhinosinusitis (CRS). Methods A systematic review was conducted in CINAHL, Cochrane Library, PubMed, and Scopus from inception to July 2025.
David Kayekjian +4 more
wiley +1 more source
Expert consensus on acupuncture for diabetic foot. [PDF]
Tang X, Li G, Wang G, Chen S, Zhang L.
europepmc +1 more source
Objective Epstein–Barr virus (EBV) has been implicated in the pathogenesis of multiple sclerosis (MS). Elevated immunoglobulin G (IgG) titers against EBV nuclear antigen 1 (EBNA1) represent the most consistent serological marker of MS risk, with levels remaining persistently elevated following disease onset.
Malina Behrens +9 more
wiley +1 more source
The Efficacy of Yanghe Decoction on Diabetic Foot: A Systematic Review and Meta-Analysis. [PDF]
Wang X, Yang Y, Pan J, Chen Q.
europepmc +1 more source
The metabolic syndrome, a state of progressive metabolic dysfunction, injures the peripheral and central nervous systems, promoting peripheral neuropathy (PN) and cognitive impairment (CI), respectively. We posit PN and CI are connected in the metabolic syndrome framework, built on the premise that neurons, whether in the peripheral or central nervous ...
Masha G. Savelieff +3 more
wiley +1 more source
Objective To evaluate the effectiveness and safety of ocrelizumab in self‐identified black and Hispanic people with relapsing multiple sclerosis. Methods The Characterization of Ocrelizumab in Minorities with Multiple Sclerosis (CHIMES) trial, a prospective, open‐label, single‐arm, phase 4 study, intentionally recruited underrepresented populations in ...
Lilyana Amezcua +16 more
wiley +1 more source
Engineered exosomes for diabetic foot ulcers: lessons learned, challenges remain. [PDF]
Jung HD.
europepmc +1 more source

